Moyamoya disease exhibits significant regional variations in incidence and clinical presentation, with higher rates in Japan and China compared to Taiwan and North America.
MMD incidence was higher in Japan and China than in Taiwan and North America and presenting symptoms showed regional differences, which are thus far unexplained. Population based data on MMD in Europe are lacking.
Kleinloog et al. (Wed,) studied this question.